Cargando…
Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis
OBJECTIVE: To evaluate the diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in patients suspected of having mild or atypical cystic fibrosis (CF). METHODS: This was a cross-sectional study involving adolescents and adults aged ≥ 14...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Pneumologia e Tisiologia
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075816/ https://www.ncbi.nlm.nih.gov/pubmed/23670503 http://dx.doi.org/10.1590/S1806-37132013000200009 |
_version_ | 1782323397899845632 |
---|---|
author | Dal'Maso, Vinícius Buaes Mallmann, Lucas Siebert, Marina Simon, Laura Saraiva-Pereira, Maria Luiza Dalcin, Paulo de Tarso Roth |
author_facet | Dal'Maso, Vinícius Buaes Mallmann, Lucas Siebert, Marina Simon, Laura Saraiva-Pereira, Maria Luiza Dalcin, Paulo de Tarso Roth |
author_sort | Dal'Maso, Vinícius Buaes |
collection | PubMed |
description | OBJECTIVE: To evaluate the diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in patients suspected of having mild or atypical cystic fibrosis (CF). METHODS: This was a cross-sectional study involving adolescents and adults aged ≥ 14 years. Volunteers underwent clinical, laboratory, and radiological evaluation, as well as spirometry, sputum microbiology, liver ultrasound, sweat tests, and molecular analysis of the CFTR gene. We then divided the patients into three groups by the number of mutations identified (none, one, and two or more) and compared those groups in terms of their characteristics. RESULTS: We evaluated 37 patients with phenotypic findings of CF, with or without sweat test confirmation. The mean age of the patients was 32.5 ± 13.6 years, and females predominated (75.7%). The molecular analysis contributed to the definitive diagnosis of CF in 3 patients (8.1%), all of whom had at least two mutations. There were 7 patients (18.9%) with only one mutation and 26 patients (70.3%) with no mutations. None of the clinical characteristics evaluated was found to be associated with the genetic diagnosis. The most common mutation was p.F508del, which was found in 5 patients. The combination of p.V232D and p.F508del was found in 2 patients. Other mutations identified were p.A559T, p.D1152H, p.T1057A, p.I148T, p.V754M, p.P1290P, p.R1066H, and p.T351S. CONCLUSIONS: The molecular analysis of the CFTR gene coding region showed a limited contribution to the diagnostic investigation of patients suspected of having mild or atypical CF. In addition, there were no associations between the clinical characteristics and the genetic diagnosis. |
format | Online Article Text |
id | pubmed-4075816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Sociedade Brasileira de Pneumologia e Tisiologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-40758162014-07-16 Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis Dal'Maso, Vinícius Buaes Mallmann, Lucas Siebert, Marina Simon, Laura Saraiva-Pereira, Maria Luiza Dalcin, Paulo de Tarso Roth J Bras Pneumol Original Article OBJECTIVE: To evaluate the diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in patients suspected of having mild or atypical cystic fibrosis (CF). METHODS: This was a cross-sectional study involving adolescents and adults aged ≥ 14 years. Volunteers underwent clinical, laboratory, and radiological evaluation, as well as spirometry, sputum microbiology, liver ultrasound, sweat tests, and molecular analysis of the CFTR gene. We then divided the patients into three groups by the number of mutations identified (none, one, and two or more) and compared those groups in terms of their characteristics. RESULTS: We evaluated 37 patients with phenotypic findings of CF, with or without sweat test confirmation. The mean age of the patients was 32.5 ± 13.6 years, and females predominated (75.7%). The molecular analysis contributed to the definitive diagnosis of CF in 3 patients (8.1%), all of whom had at least two mutations. There were 7 patients (18.9%) with only one mutation and 26 patients (70.3%) with no mutations. None of the clinical characteristics evaluated was found to be associated with the genetic diagnosis. The most common mutation was p.F508del, which was found in 5 patients. The combination of p.V232D and p.F508del was found in 2 patients. Other mutations identified were p.A559T, p.D1152H, p.T1057A, p.I148T, p.V754M, p.P1290P, p.R1066H, and p.T351S. CONCLUSIONS: The molecular analysis of the CFTR gene coding region showed a limited contribution to the diagnostic investigation of patients suspected of having mild or atypical CF. In addition, there were no associations between the clinical characteristics and the genetic diagnosis. Sociedade Brasileira de Pneumologia e Tisiologia 2013 /pmc/articles/PMC4075816/ /pubmed/23670503 http://dx.doi.org/10.1590/S1806-37132013000200009 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Dal'Maso, Vinícius Buaes Mallmann, Lucas Siebert, Marina Simon, Laura Saraiva-Pereira, Maria Luiza Dalcin, Paulo de Tarso Roth Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis |
title | Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis
|
title_full | Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis
|
title_fullStr | Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis
|
title_full_unstemmed | Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis
|
title_short | Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis
|
title_sort | diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075816/ https://www.ncbi.nlm.nih.gov/pubmed/23670503 http://dx.doi.org/10.1590/S1806-37132013000200009 |
work_keys_str_mv | AT dalmasoviniciusbuaes diagnosticcontributionofmolecularanalysisofthecysticfibrosistransmembraneconductanceregulatorgeneinpatientssuspectedofhavingmildoratypicalcysticfibrosis AT mallmannlucas diagnosticcontributionofmolecularanalysisofthecysticfibrosistransmembraneconductanceregulatorgeneinpatientssuspectedofhavingmildoratypicalcysticfibrosis AT siebertmarina diagnosticcontributionofmolecularanalysisofthecysticfibrosistransmembraneconductanceregulatorgeneinpatientssuspectedofhavingmildoratypicalcysticfibrosis AT simonlaura diagnosticcontributionofmolecularanalysisofthecysticfibrosistransmembraneconductanceregulatorgeneinpatientssuspectedofhavingmildoratypicalcysticfibrosis AT saraivapereiramarialuiza diagnosticcontributionofmolecularanalysisofthecysticfibrosistransmembraneconductanceregulatorgeneinpatientssuspectedofhavingmildoratypicalcysticfibrosis AT dalcinpaulodetarsoroth diagnosticcontributionofmolecularanalysisofthecysticfibrosistransmembraneconductanceregulatorgeneinpatientssuspectedofhavingmildoratypicalcysticfibrosis |